Figure 3 | Modern Pathology

Figure 3

From: Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: correlation with clinicopathologic parameters and biomarkers

Figure 3

AIB1. (a–d) AIB1 (BD): nuclear expression. (a) AIB1 (BD) expression in Type II endometrial carcinoma, 3+ positive ( × 200). (b) AIB1 (BD) expression in Type I endometrial carcinoma, 2+ positive ( × 200). (c) AIB1 (BD) expression in carcinoma-associated complex atypical hyperplasia, 1+ positive ( × 200). (d) AIB1 (BD) No expression in carcinoma-associated normal endometrium (negative) ( × 200). CA=endometrial carcinoma.

Back to article page